Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportOral - PhysicianPharm

68Ga-Pentixafor PET/CT in the evaluation of post-treatment response for Waldenström Macroglobulinemia/ Lymphoplasmacytic Lymphoma

Qingqing Pan, Yaping Luo, Xinxin Cao and Fang Li
Journal of Nuclear Medicine May 2021, 62 (supplement 1) 127;
Qingqing Pan
1Peking Union Medical College Hospital,Beijing China Beijing China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yaping Luo
2Peking Union Medical College Hospital Beijing China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xinxin Cao
2Peking Union Medical College Hospital Beijing China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Fang Li
2Peking Union Medical College Hospital Beijing China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
Loading

Article Information

vol. 62 no. supplement 1 127

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Published online May 18, 2021.

Copyright & Usage 
© 2021

Author Information

  1. Qingqing Pan1,
  2. Yaping Luo2,
  3. Xinxin Cao2 and
  4. Fang Li2
  1. 1Peking Union Medical College Hospital,Beijing China Beijing China
  2. 2Peking Union Medical College Hospital Beijing China

Statistics from Altmetric.com

Cited By...

  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

Article usage

Article usage: May 2021 to April 2025

AbstractFullPdf
May 20213300
Jun 20212900
Jul 20213100
Aug 20211700
Sep 20212200
Oct 2021900
Nov 20211600
Dec 2021900
Jan 20221800
Feb 2022600
Mar 2022900
Apr 20222400
May 2022900
Jun 2022700
Jul 2022700
Aug 2022600
Sep 2022400
Oct 2022300
Nov 2022700
Dec 2022500
Jan 2023600
Feb 2023400
Mar 20231100
Apr 20231200
May 2023300
Jun 2023700
Jul 2023600
Aug 2023200
Sep 2023700
Oct 20231200
Nov 2023800
Dec 2023900
Jan 20241500
Feb 2024700
Mar 2024300
Apr 20242000
May 2024900
Jun 20242200
Jul 20246700
Aug 20245600
Sep 20241800
Oct 20241600
Nov 2024500
Dec 2024600
Jan 2025400
Feb 2025500
Mar 20251500
Apr 2025900
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 62, Issue supplement 1
May 1, 2021
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
68Ga-Pentixafor PET/CT in the evaluation of post-treatment response for Waldenström Macroglobulinemia/ Lymphoplasmacytic Lymphoma
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
68Ga-Pentixafor PET/CT in the evaluation of post-treatment response for Waldenström Macroglobulinemia/ Lymphoplasmacytic Lymphoma
Qingqing Pan, Yaping Luo, Xinxin Cao, Fang Li
Journal of Nuclear Medicine May 2021, 62 (supplement 1) 127;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
68Ga-Pentixafor PET/CT in the evaluation of post-treatment response for Waldenström Macroglobulinemia/ Lymphoplasmacytic Lymphoma
Qingqing Pan, Yaping Luo, Xinxin Cao, Fang Li
Journal of Nuclear Medicine May 2021, 62 (supplement 1) 127;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Figures & Data
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Oral - PhysicianPharm

  • Optimization of 89Zr PET imaging using both phantom and clinical studies with [89Zr]-Df-IAB22M2C, an anti-CD8 minibody.
  • Progression and toxicity following liver Y90 radioembolization: impact of dose metrics, clinical factors, and biomarkers
  • Explainable prediction of all-cause mortality from myocardial PET flow and perfusion images using deep learning
Show more Oral - PhysicianPharm

Advances in PET Imaging for Cancer: Highlights of Clinical Diagnostics in Oncology

  • Ga-68-FAPI for sarcoma imaging: Data from the FAPI-PET prospective observational trial
  • Response monitoring in metastatic breast cancer: a comparison of survival times between FDG-PET/CT and CE-CT
  • A Head-to-Head Comparison of 68Ga-DOTA-FAPI-04 and 18F-FDG PET/MR in Patients with Nasopharyngeal Carcinoma: A Prospective Study
Show more Advances in PET Imaging for Cancer: Highlights of Clinical Diagnostics in Oncology

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire